Activation of ErbB2 during Wallerian degeneration of sciatic nerve

Journal of Neuroscience

Volumn 17, Issue 21, 1997, Pages 8293-8299

  Kwon, Yunhee Kim ^a,b,c   Bhattacharyya, Anita ^b,c   Alberta, John A ^b   Giannobile, William V ^b,d   Cheon, Kangwoo ^a   Stiles, Charles D ^b   Pomeroy, Scott L ^c  

^a Kyung Hee University   (South Korea)

^b HARVARD MEDICAL SCHOOL   (United States)

^c BOSTON CHILDREN S HOSPITAL   (United States)

^d HARVARD SCHOOL OF DENTAL MEDICINE   (United States)

Author keywords

ErbB2; Neuregulin; Phosphotyrosine; Receptor tyrosine kinase; Schwann cell; Wallerian degeneration

Indexed keywords

BROXURIDINE; EPIDERMAL GROWTH FACTOR RECEPTOR; GENE PRODUCT; MITOGEN ACTIVATED PROTEIN KINASE; MONOCLONAL ANTIBODY; PHOSPHOPEPTIDE; PHOSPHOTYROSINE; PROTEIN TYROSINE KINASE; RAF PROTEIN; RAS PROTEIN;

ANIMAL CELL; ANTIBODY SPECIFICITY; ARTICLE; AUTOPHOSPHORYLATION; CONTROLLED STUDY; ENZYME PHOSPHORYLATION; IMMUNOHISTOCHEMISTRY; MITOSIS; MOUSE; NERVE DEGENERATION; NONHUMAN; PRIORITY JOURNAL; SCHWANN CELL; SCIATIC NERVE; SIGNAL TRANSDUCTION;

EID: 16944363368     PISSN: 02706474     EISSN: None     Source Type: Journal    
DOI: 10.1523/jneurosci.17-21-08293.1997     Document Type: Article

References (13)

1. Akiyama T, Matsuda S, Namba Y, Saito T, Toyoshima K, Yamaoto T (1991) The transforming potential of the c-erbB-2 protein is regulated by its autophosphorylation at the carboxyl-terminal domain. Mol Cell Biol 11:833-842.
2. neu/erbB-2 and the epidermal growth factor receptor. Proc Natl Acad Sci USA 89:11637-11641.
3. Ben-Levy RB, Paterson HF, Marshall CJ, Yarden Y (1994) A single autophosphorylation site confers oncogenicity to the Neu/ErbB-2 receptor and enables coupling to the MAP kinase pathway. EMBO J 13:3302-3311.
4. Bradley WG, Asbury AK (1970) Duration of synthesis phase in neurilemma cells in mouse sciatic nerve during regeneration. Exp Neurol 26:275-282.
5. Campbell KS, Ogris O, Burke B, Su W, Auger KR, Druker BJ, Schaffhausen BS, Roberts TM, Pallas DC (1994) Polyoma middle tumor antigen interacts with SHC protein via the NPTY (Asn-Pro-Thr-Tyr) motif in middle tumor antigen. Proc Natl Acad Sci USA 91:6344-6348.
6. Carraway KI, Cantley L (1994) A neu acquaintance for ErbB3 and ErbB4: a role for receptor heterodimerization in growth signaling. Cell 78:5-8.
7. Carroll SL, Miller ML, Frohnert PW, Kim SS, Corbett JA (1997) Expression of neuregulins and their putative receptors, erbB2 and erbB3, is induced during Wallerian degeneration. J Neurosci 17:1642-1659.
8. Clemence A, Mirsky R, Jessen KR (1989) Non-myelin-forming Schwann cells proliferate rapidly during Wallerian degeneration in the rat sciatic nerve. J Neurocytol 18:185-192.
9. Cohen J, Yachnis A, Arai M, Davis J, Scherer S (1992) Expression of the neu proto-oncogene by Schwann cells during peripheral nerve development and Wallerian degeneration. J Neurosci Res 31:622-634.
10. Dilworth SM, Brewster CEP, Jonew MD, Lanfrancone L, Pelicci G, Pelicci PG (1994) Transformation by polyoma virus middle T-antigen involves the binding and tyrosine phosphorylation of She. Nature 367:87-90.
11. Ullrich A, Schlessinger J (1990) Signal transduction by receptors with tyrosine kinase activity. Cell 61:203-212.
12. Wallasch C, Weiss FU, Niederfellner G, Jallal B, Issing W, Ullrich A (1995) Heregulin-dependent regulation of HER2/neu oncogenic signaling by heterodimerization with HER3. EMBO J 14:4267-4275.
13. Waller A (1851) Experiments on the section of the glosso-pharyngeal and hypoglossal nerves of the frog, and observations of the alterations produced thereby in the structures of their primitive fibers. Edinburgh Med Surg J 76:369-376.